Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | NAMPT | P43490 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2994694 | 0.91 | HDAC3 (0.70) | RAB9ATDP1HDAC3HDAC2HDAC1 | |
| SCHEMBL9107032 | 0.89 | HDAC3 (0.65) | RAB9AHDAC3HDAC2HDAC1ALDH1A1 | |
| SCHEMBL1568235 | 0.84 | RAB9A (1.00) | RAB9ATDP1HDAC2ALDH1A1SMN1; SMN2 | |
| SCHEMBL2995747 | 0.84 | CA1 (0.67) | RAB9ATDP1HDAC3HDAC2HDAC1 | |
| SCHEMBL17833172 | 0.84 | KMT2A (0.74) | RAB9ATDP1HDAC3HDAC2HDAC1 | |
| SCHEMBL17673049 | 0.83 | RAB9A (0.97) | RAB9ATDP1HDAC2ALDH1A1SMN1; SMN2 | |
| SCHEMBL17141809 | 0.81 | HDAC3 (0.83) | RAB9AHDAC3HDAC2HDAC1GAA | |
| Nialamide SCHEMBL28086228 | 0.81 | RAB9A (0.55) | RAB9ATDP1HDAC3HDAC2HDAC1 | |
| Nialamide SCHEMBL49430 | 0.80 | CA1 (0.62) | RAB9ATDP1HDAC3HDAC2HDAC1 | |
| SCHEMBL2654333 | 0.79 | HDAC3 (0.58) | RAB9AHDAC3HDAC2HDAC1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100184811-A1 | ISONIAZID MEDIATED HEALING OF WOUNDS AND ULCERS | BRIDGE BIORESEARCH RIGHTS (JERSEY) LIMITED (GB) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184811-A1 | ISONIAZID MEDIATED HEALING OF WOUNDS AND ULCERS | ODC1, OTC, ACACB | RAB9A 4462/4885TDP1 3641/4885HDAC3 111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.